Randomized controlled clinical study on Yiqi Liangxue Shengji prescription for intervention cardiac function of acute myocardial infarction with ischemia-reperfusion injury.

Medicine (Baltimore) · 2021 · PMC7969256 · PMID 33725857

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

marginally significantno p-value reported

A P value between .1 and .05 was considered marginally significant, a P value between .01 and .05 was considered significant, .001 and .01 highly significant, and < .001 very highly significant. 2.12 Ethics and dissemination This trial has been registered at Chinese Clinical Trial Registry http://www.chictr.org.cn/showproj.aspx?proj=61713 .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.